Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy

A Review of the Virological Efficacy of the 4 World Health Organization–Recommended Tenofovir-Containing Regimens for Initial HIV Therapy

(2012) Michele W. Tang et al.   CLINICAL INFECTIOUS DISEASES

Treatment Outcomes of Recommended First-Line Antiretroviral Regimens in Resource-Limited Clinics

(2012) Anthony Amoroso et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety of efavirenz in the first trimester of pregnancy

(2011) Nathan Ford et al.   AIDS

Efficacy and Safety of Once-Daily Nevirapine- or Efavirenz-Based Antiretroviral Therapy in HIV-Associated Tuberculosis: A Randomized Clinical Trial

(2011) S. Swaminathan et al.   CLINICAL INFECTIOUS DISEASES

Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA

(2011) Vincent J. Tukei et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

(2011) Su Golder et al.   PLOS MEDICINE

Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts

(2010) Nathan Ford et al.   AIDS

Treatment Modification in Human Immunodeficiency Virus–Infected Individuals Starting Combination Antiretroviral Therapy Between 2005 and 2008

(2010) Luigia Elzi   ARCHIVES OF INTERNAL MEDICINE

Stavudine Toxicity in Women is the Main Reason for Treatment Change in a 3-Year Prospective Cohort of Adult Patients Started on First-Line Antiretroviral Treatment in Uganda

(2010) Barbara Castelnuovo et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India

(2010) Retty Rajan Modayil et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication

(2010) Erika Aaron et al.   PLoS One

Adverse effects after HAART Initiation in resource-limited settings: a prospective study from Mysore, India

(2010) Srirangaraj Sreenivasan et al.   Journal of Infection in Developing Countries

Antiretroviral treatment changes in adults from Côte dʼIvoire: the roles of tuberculosis and pregnancy

(2009) Eugène Messou et al.   AIDS

Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients

(2009) Hossein Khalili et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Spectrum of Adverse Events After Generic HAART in Southern Indian HIV-Infected Patients

(2008) N. Kumarasamy et al.   AIDS PATIENT CARE AND STDS

Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy

(2008) Andrew Boulle   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India

(2008) C. George et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Safety, Tolerability and Effectiveness of Generic HAART in HIV-Infected Children in South India

(2008) N. Kumarasamy et al.   JOURNAL OF TROPICAL PEDIATRICS

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal